U.S. FDA delays decision on Juul e-cigarettes

Health News
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

(Reuters) – The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.

The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco Plc’s Vuse and Imperial Brands Plc’s Blu, faced a deadline to file applications showing their products provided a net benefit to public health.

The agency said on Thursday that it continues to “work expeditiously on the remaining applications,” adding many are “in the final stages of review.”

Source: Read Full Article

Related posts:
  1. U.S. FDA approves Merck's Keytruda combo for early breast cancer treatment
  2. A year after COVID-19's arrival, India's active cases fall
  3. Japan finds new COVID-19 strain, while immigration centre reports infections